We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immunoassay Developed to Diagnose Human Fascioliasis

By LabMedica International staff writers
Posted on 18 Jul 2011
An immunoassay has been evaluated for its diagnostic ability to detect human immunoglobulin G (IgG) antibodies against Fasciola hepatica, a common liver fluke. More...


The indirect enzyme-linked immunosorbent assay (ELISA) that detects antibodies against F. hepatica saposin-like protein-2, was compared with another indirect ELISA that detects excretory–secretory products (FhES) from adult F. hepatica.

Scientists at the University of Puerto Rico (San Juan), analyzed the sera of 37 patients infected with F. hepatica, 40 patients with other parasitic infections, and 50 healthy controls. A recombinant F. hepatica saposin-like protein-2 product was prepared and compared with the FhES products obtained from adult flukes collected from cattle's bile ducts obtained from a slaughterhouse.

The sensitivity of both ELISA assays was 100%. However, the FhSAP2-based ELISA had a specificity of 95.6%, while that of the FhES-ELISA was 91.9%. The results indicate that FhSAP2 is more specific than FhES products as target antigen for ELISA-based serodiagnosis of human fascioliasis since the best results for specificity and accuracy were achieved with the recombinant protein. The investigators noted that the mean value for negative controls and for other groups of samples is higher for the FhSAP2-ELISA than for the FhES-ELISA assay, which leads to a higher cut-off value, and that the mean value for the positive control samples in the FhSAP2-ELISA is slightly lower than the mean value obtained for these samples in the FhES-ELISA.

The authors concluded that their results demonstrated that FhSAP2 could be used in the serodiagnosis of chronic human fascioliasis with the additional advantage of being relatively cheap and easy to produce. Studies are in progress to evaluate this FhSAP2-ELISA assay in a large-scale prevalence surveys in endemic areas. It is estimated that worldwide 180 million humans are at risk from this zoonotic disease. Typical early symptoms include fever, abdominal pain, gastrointestinal disturbances and urticaria and hepatomegaly, anemia and jaundice may also be present The article was published in July 2011, in Diagnostic Microbiology and Infectious Disease.

Related Links:
University of Puerto Rico




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
Collection and Transport System
PurSafe Plus®
New
Silver Member
PCR Plates
Diamond Shell PCR Plates
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.